Location: Home
  • search
  • go
  • Relate News
  • 10/12/2023Review of Chinese Biopharma Industry Performance in September 2023
  • 10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • 8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
  • 8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
  • 8/24/2023Review of China Performance of Leading MNCs in China H1/2023 (Updated)
  • 7/5/2023SMEI Forecasts Growth of Ex-Hospital and Innovative Drug Sales Before ...
  • 7/3/2023Innovative Drug Market Share on the Rise Continuously in Recent Years:...
  • 6/15/2023Top Ten Listed Chinese Pharma Companies by R&D Spending in 2021/2022
  • 6/1/2023NH's DB6: China's Consumer Healthcare Market Underperformed in 2022
  • 6/1/2023NH's DB6: Top Ten Chinese CHC Brands in 2021
  • 6/1/2023NH's DB6: Chinese Consumer Healthcare Market Forecast 2027/2032
  • 6/1/2023Edelman Report Finds Chinese Trusting Pharma the Most
  • 5/29/2023A Share-Listed Chinese MedPharm Cos Report Performance in 2022 with Ov...
  • 5/29/2023Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2022
  • 5/22/2023SMEI: Chinese Terminal Drug Market Growth Slowed to 1.1% in 2022 (Upda...
  • 5/18/2023Chinese A Shared-listed Pharma Companies Report Mixed Q1/2023 Performa...
  • 5/16/2023China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...
  • 4/21/2023NMPA Issues the 2022 Drug Regulatory Statistics Annual Report
  • 4/12/2023Yicai: Most Chinese Regions Eye Healthcare Industry Upgrades
  • 4/12/2023Outlook of China's Health Systems (Informa)
  • 4/1/2023China Further Intensifies Healthcare Cost Containment and Price Contro...
  • 3/29/2023Investing in China's Healthcare Sector (China Briefing)
  • 3/15/2023Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • 3/9/2023PhIIC: Chinese Retail Pharmacy Sales Fell Sharply in 2022 Despite Rebo...
  • 2/24/2023SMEI: Chinese Pharma Revenues Down 1.6% Last Year But Expected to Rebo...
  • 2/24/2023IQVIA: Chinese Hospital Drug Market Shrank 2.1% in 2022
  • 2/16/2023IQVIA: Chinese Pharma to See 2%-5% CAGR Before 2027
  • 2/10/2023China Drug Sales Performance of Top Seven MNC Pharma Cos in 2022
  • 2/2/2023Performance of A Share-listed MedPharm Cos Mixed in 2022
  • Page:3/22 Total number of articles:640: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group